Annual EBIT:
$1.58B+$248.30M(+18.62%)Summary
- As of today, UTHR annual earnings before interest & taxes is $1.58 billion, with the most recent change of +$248.30 million (+18.62%) on December 31, 2024.
- During the last 3 years, UTHR annual EBIT has risen by +$969.40 million (+158.27%).
- UTHR annual EBIT is now at all-time high.
Performance
UTHR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$389.30M+$3.10M(+0.80%)Summary
- As of today, UTHR quarterly earnings before interest & taxes is $389.30 million, with the most recent change of +$3.10 million (+0.80%) on September 30, 2025.
- Over the past year, UTHR quarterly EBIT has increased by +$46.20 million (+13.47%).
- UTHR quarterly EBIT is now at all-time high.
Performance
UTHR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$1.52B+$46.20M(+3.14%)Summary
- As of today, UTHR TTM earnings before interest & taxes is $1.52 billion, with the most recent change of +$46.20 million (+3.14%) on September 30, 2025.
- Over the past year, UTHR TTM EBIT has increased by +$236.60 million (+18.49%).
- UTHR TTM EBIT is now at all-time high.
Performance
UTHR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
UTHR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +18.6% | +13.5% | +18.5% |
| 3Y3 Years | +158.3% | +23.9% | +55.5% |
| 5Y5 Years | +1409.5% | +76.1% | +156.2% |
UTHR EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +158.3% | at high | +121.7% | at high | +55.5% |
| 5Y | 5-Year | at high | +1409.5% | at high | +496.2% | at high | +207.8% |
| All-Time | All-Time | at high | +1409.5% | at high | +390.8% | at high | +1534.6% |
UTHR EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $389.30M(+0.8%) | $1.52B(+3.1%) |
| Jun 2025 | - | $386.20M(+0.9%) | $1.47B(+4.7%) |
| Mar 2025 | - | $382.80M(+7.0%) | $1.40B(+1.9%) |
| Dec 2024 | $1.58B(+18.6%) | $357.70M(+4.3%) | $1.38B(+7.6%) |
| Sep 2024 | - | $343.10M(+7.3%) | $1.28B(+1.3%) |
| Jun 2024 | - | $319.90M(-10.2%) | $1.26B(+0.5%) |
| Mar 2024 | - | $356.30M(+37.0%) | $1.26B(+6.1%) |
| Dec 2023 | $1.33B(+35.7%) | $260.10M(-20.5%) | $1.18B(+7.7%) |
| Sep 2023 | - | $327.00M(+4.3%) | $1.10B(+1.2%) |
| Jun 2023 | - | $313.40M(+10.2%) | $1.09B(+11.4%) |
| Mar 2023 | - | $284.40M(+62.0%) | $976.10M(-0.4%) |
| Dec 2022 | $983.00M(+60.5%) | $175.60M(-44.1%) | $979.70M(+0.5%) |
| Sep 2022 | - | $314.30M(+55.7%) | $974.90M(+9.5%) |
| Jun 2022 | - | $201.80M(-29.9%) | $890.50M(-2.2%) |
| Mar 2022 | - | $288.00M(+68.6%) | $910.90M(+32.3%) |
| Dec 2021 | $612.50M(-7.5%) | $170.80M(-25.7%) | $688.50M(+18.1%) |
| Sep 2021 | - | $229.90M(+3.5%) | $583.00M(+1.5%) |
| Jun 2021 | - | $222.20M(+238.7%) | $574.20M(+16.6%) |
| Mar 2021 | - | $65.60M(+0.5%) | $492.50M(-17.0%) |
| Dec 2020 | $662.40M(+648.3%) | $65.30M(-70.5%) | $593.60M(+0.3%) |
| Sep 2020 | - | $221.10M(+57.4%) | $591.80M(+6.8%) |
| Jun 2020 | - | $140.50M(-15.7%) | $554.10M(-13.9%) |
| Mar 2020 | - | $166.70M(+162.5%) | $643.80M(+3.6%) |
| Dec 2019 | -$120.80M(-115.6%) | $63.50M(-65.4%) | $621.20M(-9.9%) |
| Sep 2019 | - | $183.40M(-20.3%) | $689.60M(+4.8%) |
| Jun 2019 | - | $230.20M(+59.8%) | $658.30M(+2.0%) |
| Mar 2019 | - | $144.10M(+9.2%) | $645.50M(-20.1%) |
| Dec 2018 | $772.80M(-0.7%) | $131.90M(-13.3%) | $808.30M(-0.9%) |
| Sep 2018 | - | $152.10M(-30.0%) | $815.40M(-17.4%) |
| Jun 2018 | - | $217.40M(-29.2%) | $987.10M(-7.6%) |
| Mar 2018 | - | $306.90M(+120.8%) | $1.07B(+4.2%) |
| Dec 2017 | $778.50M(-26.8%) | $139.00M(-57.1%) | $1.02B(-3.3%) |
| Sep 2017 | - | $323.80M(+8.5%) | $1.06B(+8.7%) |
| Jun 2017 | - | $298.50M(+13.2%) | $974.90M(+1.4%) |
| Mar 2017 | - | $263.60M(+51.3%) | $961.60M(-9.4%) |
| Dec 2016 | $1.06B(+1.4%) | $174.20M(-27.0%) | $1.06B(+1.8%) |
| Sep 2016 | - | $238.60M(-16.3%) | $1.04B(-12.5%) |
| Jun 2016 | - | $285.20M(-21.6%) | $1.19B(+10.5%) |
| Mar 2016 | - | $363.70M(+134.6%) | $1.08B(+54.2%) |
| Dec 2015 | $1.05B(+93.3%) | $155.06M(-59.9%) | $699.01M(-3.3%) |
| Sep 2015 | - | $387.08M(+125.4%) | $722.53M(+138.3%) |
| Jun 2015 | - | $171.71M(+1258.1%) | $303.22M(-1.5%) |
| Mar 2015 | - | -$14.83M(-108.3%) | $307.83M(-42.9%) |
| Dec 2014 | $542.80M(+82.8%) | $178.58M(+654.0%) | $538.80M(+62.4%) |
| Sep 2014 | - | -$32.24M(-118.3%) | $331.73M(-29.2%) |
| Jun 2014 | - | $176.32M(-18.4%) | $468.62M(+13.0%) |
| Mar 2014 | - | $216.14M(+858.6%) | $414.60M(+41.7%) |
| Dec 2013 | $296.96M(-35.1%) | -$28.49M(-127.2%) | $292.50M(-34.9%) |
| Sep 2013 | - | $104.65M(-14.4%) | $449.59M(+5.6%) |
| Jun 2013 | - | $122.30M(+30.1%) | $425.66M(+2.4%) |
| Mar 2013 | - | $94.04M(-26.9%) | $415.75M(-3.0%) |
| Dec 2012 | $457.31M | $128.60M(+59.3%) | $428.45M(+17.9%) |
| Sep 2012 | - | $80.72M(-28.2%) | $363.35M(-5.8%) |
| Jun 2012 | - | $112.39M(+5.3%) | $385.61M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $106.74M(+68.1%) | $387.71M(+22.0%) |
| Dec 2011 | $320.48M(+83.3%) | $63.51M(-38.3%) | $317.86M(+133.8%) |
| Sep 2011 | - | $102.98M(-10.1%) | $135.96M(+43.1%) |
| Jun 2011 | - | $114.49M(+210.4%) | $95.03M(+129.7%) |
| Mar 2011 | - | $36.88M(+131.2%) | $41.36M(+12.6%) |
| Dec 2010 | $174.86M(+452.6%) | -$118.39M(-290.8%) | $36.73M(-76.8%) |
| Sep 2010 | - | $62.05M(+2.0%) | $158.00M(+46.7%) |
| Jun 2010 | - | $60.83M(+88.6%) | $107.69M(+152.0%) |
| Mar 2010 | - | $32.25M(+1021.2%) | $42.74M(+37.6%) |
| Dec 2009 | $31.64M(+143.8%) | $2.88M(-75.5%) | $31.06M(+129.4%) |
| Sep 2009 | - | $11.74M(+384.8%) | -$105.68M(-6.4%) |
| Jun 2009 | - | -$4.12M(-120.0%) | -$99.35M(-30.3%) |
| Mar 2009 | - | $20.57M(+115.4%) | -$76.24M(+7.1%) |
| Dec 2008 | -$72.28M(-485.3%) | -$133.86M(-841.2%) | -$82.06M(-280.4%) |
| Sep 2008 | - | $18.06M(-4.9%) | $45.48M(+9.4%) |
| Jun 2008 | - | $18.99M(+28.7%) | $41.57M(+35.7%) |
| Mar 2008 | - | $14.75M(+333.2%) | $30.63M(+265.9%) |
| Dec 2007 | $18.76M(-35.3%) | -$6.33M(-144.7%) | $8.37M(-54.1%) |
| Sep 2007 | - | $14.16M(+76.0%) | $18.25M(+17.5%) |
| Jun 2007 | - | $8.04M(+207.2%) | $15.52M(-18.3%) |
| Mar 2007 | - | -$7.50M(-311.5%) | $18.99M(-38.7%) |
| Dec 2006 | $28.98M(-32.4%) | $3.55M(-69.0%) | $31.01M(-18.0%) |
| Sep 2006 | - | $11.43M(-0.7%) | $37.81M(-7.6%) |
| Jun 2006 | - | $11.52M(+155.5%) | $40.91M(+0.9%) |
| Mar 2006 | - | $4.51M(-56.5%) | $40.56M(-5.4%) |
| Dec 2005 | $42.89M(+224.7%) | $10.36M(-28.8%) | $42.89M(+10.4%) |
| Sep 2005 | - | $14.54M(+30.2%) | $38.85M(+29.4%) |
| Jun 2005 | - | $11.16M(+63.2%) | $30.01M(+33.9%) |
| Mar 2005 | - | $6.84M(+8.3%) | $22.42M(+69.7%) |
| Dec 2004 | $13.21M(+214.6%) | $6.31M(+10.8%) | $13.21M(+291.6%) |
| Sep 2004 | - | $5.70M(+59.6%) | $3.37M(+182.9%) |
| Jun 2004 | - | $3.57M(+250.5%) | -$4.07M(+61.1%) |
| Mar 2004 | - | -$2.37M(+32.6%) | -$10.47M(+9.2%) |
| Dec 2003 | -$11.53M(+36.0%) | -$3.52M(-102.1%) | -$11.53M(-3.7%) |
| Sep 2003 | - | -$1.74M(+38.4%) | -$11.12M(+30.1%) |
| Jun 2003 | - | -$2.83M(+17.6%) | -$15.91M(-10.0%) |
| Mar 2003 | - | -$3.43M(-10.2%) | -$14.46M(+19.7%) |
| Dec 2002 | -$18.00M(+61.6%) | -$3.11M(+52.4%) | -$18.00M(+26.2%) |
| Sep 2002 | - | -$6.54M(-374.0%) | -$24.40M(+18.0%) |
| Jun 2002 | - | -$1.38M(+80.2%) | -$29.76M(+28.0%) |
| Mar 2002 | - | -$6.97M(+26.7%) | -$41.36M(+11.9%) |
| Dec 2001 | -$46.94M(+42.4%) | -$9.51M(+20.1%) | -$46.94M(+23.5%) |
| Sep 2001 | - | -$11.90M(+8.3%) | -$61.40M(-2.5%) |
| Jun 2001 | - | -$12.97M(-3.3%) | -$59.92M(+22.7%) |
| Mar 2001 | - | -$12.56M(+47.6%) | -$77.47M(-4.1%) |
| Dec 2000 | -$81.50M(-130.5%) | -$23.97M(-130.0%) | -$74.40M(-23.9%) |
| Sep 2000 | - | -$10.42M(+65.8%) | -$60.03M(-5.8%) |
| Jun 2000 | - | -$30.52M(-221.6%) | -$56.76M(-74.6%) |
| Mar 2000 | - | -$9.49M(+1.1%) | -$32.50M(+8.2%) |
| Dec 1999 | -$35.36M(-165.0%) | -$9.59M(-34.1%) | -$35.42M(-37.1%) |
| Sep 1999 | - | -$7.16M(-14.2%) | -$25.83M(-38.3%) |
| Jun 1999 | - | -$6.26M(+49.5%) | -$18.67M(-50.5%) |
| Mar 1999 | - | -$12.41M | -$12.41M |
| Dec 1998 | -$13.35M | - | - |
FAQ
- What is United Therapeutics Corporation annual earnings before interest & taxes?
- What is the all-time high annual EBIT for United Therapeutics Corporation?
- What is United Therapeutics Corporation annual EBIT year-on-year change?
- What is United Therapeutics Corporation quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for United Therapeutics Corporation?
- What is United Therapeutics Corporation quarterly EBIT year-on-year change?
- What is United Therapeutics Corporation TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for United Therapeutics Corporation?
- What is United Therapeutics Corporation TTM EBIT year-on-year change?
What is United Therapeutics Corporation annual earnings before interest & taxes?
The current annual EBIT of UTHR is $1.58B
What is the all-time high annual EBIT for United Therapeutics Corporation?
United Therapeutics Corporation all-time high annual earnings before interest & taxes is $1.58B
What is United Therapeutics Corporation annual EBIT year-on-year change?
Over the past year, UTHR annual earnings before interest & taxes has changed by +$248.30M (+18.62%)
What is United Therapeutics Corporation quarterly earnings before interest & taxes?
The current quarterly EBIT of UTHR is $389.30M
What is the all-time high quarterly EBIT for United Therapeutics Corporation?
United Therapeutics Corporation all-time high quarterly earnings before interest & taxes is $389.30M
What is United Therapeutics Corporation quarterly EBIT year-on-year change?
Over the past year, UTHR quarterly earnings before interest & taxes has changed by +$46.20M (+13.47%)
What is United Therapeutics Corporation TTM earnings before interest & taxes?
The current TTM EBIT of UTHR is $1.52B
What is the all-time high TTM EBIT for United Therapeutics Corporation?
United Therapeutics Corporation all-time high TTM earnings before interest & taxes is $1.52B
What is United Therapeutics Corporation TTM EBIT year-on-year change?
Over the past year, UTHR TTM earnings before interest & taxes has changed by +$236.60M (+18.49%)